Preparations for Invasion: Modulation of Host Lung Immunity During Pulmonary Aspergillosis by Gliotoxin and Other Fungal Secondary Metabolites.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic search or meta-analysis
PubMed 30459771 · doi:10.3389/fimmu.2018.02549
What was done
The authors synthesized published literature on host lung immune defenses against Aspergillus and reviewed the immunosuppressive mechanisms of fungal secondary metabolites. The review focused specifically on gliotoxin, evaluated evidence from animal infection models across differing host immune states, and examined predisposing human clinical conditions to assess gliotoxin as a potential therapeutic target.
What was found
The abstract reports no numerical findings. Conceptually, it describes how fungal secondary metabolism is activated during infection to produce virulence factors that aid dissemination. Gliotoxin acts as a primary virulence factor capable of generating reactive oxygen species via its disulfide bridge, killing mammalian host cells, and inactivating critical immune signaling pathways such as NF-κB.
Why it matters
Elucidating how gliotoxin modulates pulmonary immunity identifies key pathways of fungal immune evasion and highlights potential targets for treating invasive aspergillosis in high-risk patients.
Limits
The abstract describes a narrative review rather than a systematic review or empirical clinical trial. No quantitative data, sample sizes, or search methodologies are reported, and the mechanistic conclusions rely primarily on animal models and bench-level assays.
Cited by
- supports Gliotoxins produced by mold have immunosuppressive properties.